Novogen Limited (ADR) - NVGN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Novogen Limited (ADR) - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
NVGN	Nasdaq	8731	http://www.novogen.com	4.09 +0.06
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Novogen Limited (ADR) 5 Stocks Poised to Break Out - May 10th, 2013 12:05 pm Share Purchase Plan Cleansing Notice - Apr 22nd, 2013 5:25 am 12 April Capital Raising-CEO’s Blog - Apr 17th, 2013 9:45 am U.S. Food and Drug Administration Approved 30% More Drugs in 2012 - Feb 26th, 2013 6:20 am The Monday Morning Quarterback - Feb 25th, 2013 8:28 am 4 Healthcare Stock Stories for Tuesday Wellness - Feb 19th, 2013 1:45 pm Will Novogen’s Positive Drug Results Attract These Top Institutional Shareholders? - Feb 19th, 2013 12:42 pm Best Buy Severs Relationship With Cap One and 3 Hot Stocks Trading Today - Feb 19th, 2013 9:18 am ASX Release Allocation of Shares to Triaxial Pharmaceutical Share Holders - Feb 5th, 2013 12:10 am Novogen Announces Filing of Key Patent Application - Feb 5th, 2013 12:10 am 7 Under-$10 Stocks Rising on Explosive Volume - Nov 29th, 2012 1:03 pm Novogen signs non-binding term sheet with Triaxial Pharmaceuticals shareholders - Nov 15th, 2012 4:49 am Market Taken to the Woodshed Amid Political Posturing - Nov 14th, 2012 3:00 pm Chairman's address at the 2012 Annual General Meeting - Nov 12th, 2012 4:24 am Change of Directors at Novogen - Nov 8th, 2012 2:49 am Novogen announces updated ratio for proposed MEI share distribution - Nov 8th, 2012 2:48 am MEI Pharma reports new data in clinical trial of Pracinostat and Azacitidine - Nov 7th, 2012 2:08 am MEI Pharma announces US$27.5m private placement - Nov 6th, 2012 1:51 am NOVOGEN LTD Financials - Nov 1st, 2012 11:04 am Novogen files form 20-F as a routine filing in the US - Oct 30th, 2012 2:50 am View All Current Headlines >>